Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses

GlaxoSmithKline plc GSK reported adjusted earnings of 79 cents per American depositary share (“ADS”) for the first quarter of 2019, which beat the Zacks Consensus Estimate of 66 cents. Earnings were up 18% year over year at constant exchange rate (“CER”).